Two major strategies are being pursued to tackle tumor angiogenesis, 1) down-regulation of pro-angiogenic factors expression, such as VEGF; and 2) up-regulation of expression of anti-angiogenic factors, such as angiostatin, endostatin or TSP-1s (reviewed in [25]). This evidence concerns the gene VEGFA and neoplasm.